Advances in Pneumococcal Disease Prevention: 13-Valent Pneumococcal Conjugate Vaccine for Infants and Children

African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults

(2010) Bradford D Gessner et al.   BMC INFECTIOUS DISEASES

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

(2010) William P Hausdorff et al.   BMC Pediatrics

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

(2010) S. Esposito et al.   Clinical and Vaccine Immunology

Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis

(2010) Daniel M. Weinberger et al.   CLINICAL INFECTIOUS DISEASES

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

(2010) Deborah Lehmann et al.   CLINICAL INFECTIOUS DISEASES

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period

(2010) J. Liñares et al.   CLINICAL MICROBIOLOGY AND INFECTION

Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland

(2010) M. Patrzałek et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

(2010) Ralf R Reinert et al.   Expert Review of Vaccines

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

(2010) Matthew D. Snape et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of Alternative Regimens of the Conjugated 7-Valent Pneumococcal Vaccine

(2010) Noga Givon-Lavi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

(2010)   PEDIATRICS

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine

(2010) K. A. Bryant et al.   PEDIATRICS

Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children

(2010) S. L. Kaplan et al.   PEDIATRICS

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

(2010) S. H. Yeh et al.   PEDIATRICS

World Pneumonia Day: Fighting pneumonia with safe and affordable vaccines

(2010) Ron Dagan et al.   VACCINE

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

(2010) Jaime L. Rubin et al.   VACCINE

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

(2010) Dorothee M. Kieninger et al.   VACCINE

Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development

(2010) Rene Reinert et al.   VACCINE

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe

(2009) Markus Rose et al.   Expert Review of Vaccines

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Reduced Physician Claims for Otitis Media After Implementation of Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada

(2009) Philippe De Wals et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome

(2009) Simon Rückinger et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

(2009) Simon Rückinger et al.   VACCINE

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

(2009) Julie A. Bettinger et al.   VACCINE

Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population-Based Cohort Study

(2009) Zitta B. Harboe et al.   PLOS MEDICINE

Safety profile of pneumococcal conjugate vaccines: systematic review of pre-and post-licensure data

(2008) Frank DeStefano   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era

(2008) Ener Cagri Dinleyici et al.   Expert Review of Vaccines

Pneumonia After Implementation of the Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada

(2008) Philippe De Wals et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997-2004

(2008) F. Zhou et al.   PEDIATRICS